FDA Provides Guidance On 510(k) Devices With Different Technological Characteristics

FDA issues a draft guidance July 15 describing how it weighs the risks and benefits to prove substantial equivalency in 510(k) devices when the new product’s technological characteristics differ from its predicate device.

A new FDA draft guidance

lays out the steps it uses to assess risks and benefits for “substantial equivalency” of devices when they have different technological characteristics than their predicates.

More from Regulation

More from Policy & Regulation